Publikationen von C. W. Turck

Martins-de-Souza, D.; Schmitt, A.; Roder, R.; Lebar, M.; Schneider-Axmann, T.; Falkai, P.; Turck, C. W.: Sex-specific proteome differences in the anterior cingulate cortex of schizophrenia. Journal of Psychiatric Research 44 (14), S. 989 - 991 (2010)

Martins-De-Souza, D.; Harris, L. W.; Guest, P. C.; Turck, C. W.; Bahn, S.: The role of proteomics in depression research. European Archives of Psychiatry and Clinical Neuroscience 260 (6), S. 499 - 506 (2010)

Martins-De-Souza, D.; Wobrock, T.; Zerr, I.; Schmitt, A.; Gawinecka, J.; Schneider-Axmann, T.; Falkai, P.; Turck, C. W.: Different apolipoprotein E, apolipoprotein A1 and prostaglandin-H2 D-isomerase levels in cerebrospinal fluid of schizophrenia patients and healthy controls. World Journal of Biological Psychiatry 11 (5), S. 719 - 728 (2010)

Ditzen, C.; Varadarajulu, J.; Czibere, L.; Gonik, M.; Targosz, B. S.; Hambsch, B.; Bettecken, T.; Kessler, M. S.; Frank, E.; Bunck, M. et al.; Teplytska, L.; Erhardt, A.; Holsboer, F.; Mueller-Myhsok, B.; Landgraf, R.; Turck, C. W.: Proteomic-based genotyping in a mouse model of trait anxiety exposes disease-relevant pathways. Molecular Psychiatry 15 (7), S. 702 - 711 (2010)

Hambsch, B.; Chen, B. G.; Brenndörfer, J.; Meyer, M.; Avrabos, C.; Maccarrone, G.; Liu, R. H.; Eder, M.; Turck, C. W.; Landgraf, R.: Methylglyoxal-mediated anxiolysis involves increased protein modification and elevated expression of glyoxalase 1 in the brain. Journal of Neurochemistry 113 (5), S. 1240 - 1251 (2010)

Filiou, M. D.; Bisle, B.; Reckow, S.; Teplytska, L.; Maccarrone, G.; Turck, C. W.: Profiling of mouse synaptosome proteome and phosphoproteome by IEF. Electrophoresis 31 (8), S. 1294 - 1301 (2010)

Martins-De-Souza, D.; Dias-Neto, E.; Schmitt, A.; Falkai, P.; Gormanns, P.; Maccarrone, G.; Turck, C. W.; Gattaz, W. F.: Proteome analysis of schizophrenia brain tissue. World Journal of Biological Psychiatry 11 (2), S. 110 - 120 (2010)

Domenici, E.; Wille, D. R.; Tozzi, F.; Prokopenko, I.; Miller, S.; McKeown, A.; Brittain, C.; Rujescu, D.; Giegling, I.; Turck, C. W. et al.; Holsboer, F.; Bullmore, E. T.; Middleton, L.; Merlo-Pich, E.; Alexander, R. C.; Muglia, P.: Plasma Protein Biomarkers for Depression and Schizophrenia by Multi Analyte Profiling of Case-Control Collections. PLoS ONE 5 (2), e9166, doi: 10.1371/journal.pone.0009166 (2010)

Maccarrone, G.; Turck, C. W.; Martins-de-Souza, D.: Shotgun Mass Spectrometry Workflow Combining IEF and LC-MALDI-TOF/TOF. Protein Journal 29 (2), S. 99 - 102 (2010)

Martins-de-Souza, D.; Maccarrone, G.; Wobrock, T.; Zerr, I.; Gormanns, P.; Reckow, S.; Falkai, P.; Schmitt, A.; Turck, C. W.: Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfinction and potential biomarkers candidates for schizophrenia. Journal of Psychiatric Research 44, S. 1176 - 1189 (2010)

Frank, E.; Kessler, M. S.; Filiou, M. D.; Zhang, Y. Y.; Maccarrone, G.; Reckow, S.; Bunck, M.; Heumann, H.; Turck, C. W.; Landgraf, R. et al.; Hambsch, B.: Stable Isotope Metabolic Labeling with a Novel N-15-Enriched Bacteria Diet for Improved Proteomic Analyses of Mouse Models for Psychopathologies. PLoS ONE 4 (11), doi: 10.1371/journal.pone.0007821 (2009)

Jastorff, A. M.; Haegler, K.; Maccarrone, G.; Holsboer, F.; Weber, F.; Ziemssen, T.; Turck, C. W.: Regulation of proteins mediating neurodegeneration in experimental autoimmune encephalomyelitis and multiple sclerosis. Proteomics Clinical Applications 3 (11), S. 1273 - 1287 (2009)

Ditzen, C.; Varadarajulu, J.; Czibere, L.; Gonik, M.; Bunck, M.; Teplytska, L.; Müller-Myhsok, B.; Holsboer, F.; Landgraf, R.; Turck, C. W.: Proteomic genotyping in a mouse model of trait anxiety exposes disease relevant pathways. Pharmacopsychiatry 42 (5), S. 215 - 216 (2009)

Filiou, M. D.; Zhang, Y. Y.; Bisle, B.; Frank, E.; Kessler, M. S.; Teplytska, L.; Reckow, S.; Haegler, K.; Maccarrone, G.; Hambsch, B. et al.; Landgraf, R.; Turck, C. W.: Stable isotope metabolic labeling of a mouse model reveals synaptic biomarkers for anxiety disorders. Pharmacopsychiatry 42 (5), S. 217 - 217 (2009)

Kirmeier, T.; Ganal, V.; Ranganath, G.; Flachskamm, C.; Maccarrone, G.; Turck, C. W.; Hausch, F.; Holsboer, F.; Rein, T.: Modified antidepressants as innovative tools for identifying novel drug targets. Pharmacopsychiatry 42 (5), S. 226 - 226 (2009)

Zhang, Y. Y.; Webhofer, C.; Reckow, S.; Filiou, M. D.; Maccarrone, G.; Turck, C. W.: A MS data search method for improved N-15-labeled protein identification. Proteomics 9 (17), S. 4265 - 4270 (2009)

Martins-De-Souza, D.; Gattaz, W. F.; Schmitt, A.; Maccarrone, G.; Hunyadi-Gulyas, E.; Eberlin, M. N.; Souza, G. H. M. F.; Marangoni, S.; Novello, J. C.; Turck, C. W. et al.; Dias-Neto, E.: Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia. Journal of Psychiatric Research 43 (11), S. 978 - 986 (2009)

Otte, D. M.; Bilkei-Gorzo, A.; Filiou, M. D.; Turck, C. W.; Yilmaz, O.; Holst, M. I.; Schilling, K.; Abou-Jamra, R.; Schumacher, J.; Benzel, I. et al.; Kunz, W. S.; Beck, H.; Zimmer, A.: Behavioral changes in G72/G30 transgenic mice. European Neuropsychopharmacology 19 (5), S. 339 - 348 (2009)

Martins-De-Souza, D.; Gattaz, W. F.; Schmitt, A.; Novello, J. C.; Marangoni, S.; Turck, C. W.; Dias-Neto, E.: Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulation. BMC Psychiatry 9 (17), doi: 10.1186/1471-244X-9-17 (2009)

Martins-De-Souza, D.; Gattaz, W. F.; Schmitt, A.; Rewerts, C.; Maccarrone, G.; Dias-Neto, E.; Turck, C. W.: Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience 259 (3), S. 151 - 163 (2009)